Skip to main content

Table 2 Subgroup analysis of univariate and multivariate overall survival

From: Prognostic value of albumin-bilirubin grade in patients with cholangiocarcinoma: a systematic review and meta-analysis

Stratified analysis

Number of studies in univariate analysis

HR with 95% CI

P value

I2

Number of studies in multivariate analysis

HR with 95% CI

P value

I2

ALBI grade

 2 vs 1

7

2.20 (1.83–2.64)

 < 0.01

14%

6

2.14 (1.50–3.05)

 < 0.01

54%

 High vs low

4

1.96 (1.45–2.65)

 < 0.01

56%

2

2.15 (0.56–8.17)

0.26

80%

 2–3 vs 1

3

1.60 (1.34–1.92)

 < 0.01

0

1

1.36 (1.04–1.78)

  

Treatment

 Surgery

9

1.91 (1.64–2.22)

 < 0.01

56%

6

1.63 (1.26–2.11)

 < 0.01

54%

 Multiple

3

1.37 (0.86–2.18)

0.19

0

    

 MWA

2

3.92 (1.86–8.25)

 < 0.01

0

2

8.87 (2.48–31.71)

 < 0.01

0

 MWA + surgery

    

1

2.36 (0.98–3.77)

  

Sample size

 Over 200

5

1.69 (1.50–1.90)

 < 0.01

0

3

1.34 (1.11–1.61)

 < 0.01

0

 Below 200

9

2.32 (1.98–2.72)

 < 0.01

24%

6

2.56 (1.90–3.45)

 < 0.01

17%

Quality score

 ≥ 8 score

9

1.93 (1.63–2.28)

 < 0.01

53%

7

1.68 (1.28–2.20)

 < 0.01

59%

 < 8 score

5

1.84 (1.29–2.62)

 < 0.01

42%

2

2.86 (1.55–5.29)

 < 0.01

7%

  1. MWA Microwave ablation